Process for manufacturing sterile ophthalmic pharmaceutical suspensions
US10463674B2 · kind B2 · utility
0Cited by
0References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 5, 2014 |
| Grant date | Nov 5, 2019 |
| Priority date | — |
| Expiry date | Nov 5, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/34
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a process of manufacturing a sterile, ophthalmic pharmaceutical suspension comprising sterile active ingredient(s) such as sterile carbonic anhydrase inhibitors (CAIs) wherein the process does not involve the use of any special equipment's such as ball mill, milling bottle and/or jet mill The present process is simple, cost effective and efficient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.